These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Surgical management of neurocysticercosis. Rajshekhar V Int J Surg; 2010; 8(2):100-4. PubMed ID: 20045747 [TBL] [Abstract][Full Text] [Related]
23. [Neurocysticercosis: a rare cause of convulsive crises]. Domenici R; Matteucci L; Meossi C; Stefani G; Frugoli G Pediatr Med Chir; 1995; 17(6):577-81. PubMed ID: 8668597 [TBL] [Abstract][Full Text] [Related]
24. [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller]. Epelboin L; Klement E; Chemali N; Danis M; Bricaire E; Caumes E Bull Soc Pathol Exot; 2004 Nov; 97(4):250-2. PubMed ID: 17304744 [TBL] [Abstract][Full Text] [Related]
25. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel? Romo ML; Carpio A; Kelvin EA J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292 [TBL] [Abstract][Full Text] [Related]
26. [Neurocysticercosis--pathogenesis and clinical aspects]. Nikolić S; Stevanović G Srp Arh Celok Lek; 2006; 134(5-6):246-50. PubMed ID: 16972416 [TBL] [Abstract][Full Text] [Related]
27. [Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis]. Alla P; Carli P; Paris JF; Chagnon A Med Trop (Mars); 1996; 56(3):308. PubMed ID: 9026603 [No Abstract] [Full Text] [Related]
28. Advances in treatment of neurocysticercosis. Agarwal AK; Dudeja RK; Chandra S J Assoc Physicians India; 1994 Jan; 42(1):88. PubMed ID: 7836272 [No Abstract] [Full Text] [Related]
29. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis. Jung-Cook H Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156 [TBL] [Abstract][Full Text] [Related]
31. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology]. Herrera LA; Benítez-Bribiesca L; Sotelo J; Ostrosky-Wegman P Gac Med Mex; 2000; 136(5):477-89. PubMed ID: 11080931 [TBL] [Abstract][Full Text] [Related]
32. [Therapeutic approach to neurocysticercosis]. Canak G; Ilić A Med Pregl; 1998; 51 Suppl 1():57-60. PubMed ID: 9769658 [TBL] [Abstract][Full Text] [Related]
33. [Enlargement of an extraocular eye muscle: a symptom of cysticercosis]. Schriever S; Hasenfratz G; Hintschich C; Landau K Klin Monbl Augenheilkd; 1999 Nov; 215(5):321-4. PubMed ID: 10609250 [TBL] [Abstract][Full Text] [Related]
34. Antiparasitic treatment of cerebral cysticercosis: lessons and experiences from China. Wu W; Jia F; Wang W; Huang Y; Huang Y Parasitol Res; 2013 Aug; 112(8):2879-90. PubMed ID: 23695946 [TBL] [Abstract][Full Text] [Related]
35. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Medina MT; Rosas E; Rubio-Donnadieu F; Sotelo J Arch Intern Med; 1990 Feb; 150(2):325-7. PubMed ID: 2302008 [TBL] [Abstract][Full Text] [Related]
37. [Cerebral cysticercosis treated by albendazole: development of cerebral magnetic resonance imaging]. Ghariani S; Gille M; Matthijs P; Delbecq J; Depré A Rev Neurol (Paris); 1994 Oct; 150(10):709-12. PubMed ID: 7792479 [TBL] [Abstract][Full Text] [Related]
38. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel. Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213 [TBL] [Abstract][Full Text] [Related]
39. [Intraspinal manifestation of cysticercosis--Cysticercus racemosus. A case report and review of the literature]. Malzacher VD; Bogumil-Schott E; Neu IS Nervenarzt; 1994 Aug; 65(8):563-7. PubMed ID: 7969656 [TBL] [Abstract][Full Text] [Related]